Evidence map›Paper›PMID 35466994›Full record

ArticleStem cells translational medicine2022

Intrathecal Injection of Mesenchymal Stromal Cell Cultured on 3D Fiber Ameliorates Multiple Organ Damage in Murine Lupus.

Yuki Saito, Maki Miyajima, Sena Yamamoto, Norihiro Miura, Tsukasa Sato, Arisa Kita, Shogo Ijima, Mineko Fujimiya, Takako S Chikenji

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuki SaitoDepartment of Anatomy, Sapporo Medical University School of Medicine, Sapporo, Japan.ORCID 0000-0002-7949-1628
Maki MiyajimaGraduate School of Health Sciences, Hokkaido University, Sapporo, Japan.
Sena YamamotoGraduate School of Health Sciences, Hokkaido University, Sapporo, Japan.
Norihiro MiuraGraduate School of Health Sciences, Hokkaido University, Sapporo, Japan.
Tsukasa SatoGraduate School of Health Sciences, Hokkaido University, Sapporo, Japan.
Arisa KitaDepartment of Plastic and Reconstructive Surgery, Sapporo Medical University, Sapporo, Japan.
Shogo IjimaDepartment of Oral Surgery, Sapporo Medical University, Sapporo, Japan.
Mineko FujimiyaDepartment of Anatomy, Sapporo Medical University School of Medicine, Sapporo, Japan.
Takako S ChikenjiDepartment of Anatomy, Sapporo Medical University School of Medicine, Sapporo, Japan.ORCID 0000-0003-2832-3656
Sapporo Medical University · JPSapporo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Up to 60% of patients with systemic lupus erythematosus (SLE) experience autonomic symptom. Sympathetic nervous system damage can cause dysfunction of the bone marrow that activates inflammatory cells, potentially causing multiple organ damage. We hypothesized that sympathetic nervous system damage would induce bone marrow dysfunction with multiple organ damage in SLE, and that multiple organ damage could be improved by therapy targeting the nervous system. Here, we showed that damage to autonomic nerves and Schwann cells occurred in the bone marrow and central nervous system of SLE model mice. A neurotoxic drug increased mortality and induced severe neuropathy and multiple organ damage, while a neuroprotective drug prevented multiple organ damage. The administration of bone marrow-derived mesenchymal stromal cells (BMSCs) cultured on a 3-dimensional fiber scaffold improved bone marrow neuropathy, skin lesions, kidney function, and mortality. Our results reveal that bone marrow neuropathy influence multiple organ damage associated with SLE, and improvement of bone marrow neuropathy by intrathecal injection of BMSC may be a target for SLE multiple-organ damage.

Indexed as

Lupus Erythematosus, SystemicMesenchymal Stem CellsAnimalsBone MarrowBone Marrow CellsHumansInjections, SpinalMicebone marrowmesenchymal stromal cellmultiple organ damagesympathetic nervous systemsystemic lupus erythematosus

Identifiers

PMID35466994
PMCPMC9216504
OpenAlexW4224444523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.